Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. A Systematic Review and Meta-analysis
Laith Al-Showbaki, Ahmad A. Toubasi, Dunia Z. Jaber, Mohammad Al Shdifat, Noor Almaani, Omar Alqudah, Feras Al-Fararjeh, Eitan Amir · Journal of Cancer · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2024
Abstract
Background: There remains a scarcity of published data on the clinical significance of paraneoplastic cutaneous manifestations in hepatocellular carcinoma (HCC).Method: A systematic search of MEDLINE was performed in December 2022.Inclusion criteria comprised studies reporting on patients with HCC, who had paraneoplastic cutaneous manifestations.Outcomes of interests comprise survival and response to cancer-directed and/or skin directed therapy.Results: A total of 48 studies comprising 60 HCC patients were included in the analysis.The most frequent reported skin abnormalities were dermatomyositis, pityriasis rotunda, and porphyria.Most patients presented with dermatomyositis had underlying viral hepatitis, while all reported porphyria and acanthosis cases were associated with metabolic causes of HCC, such as steatosis.Paraneoplastic skin changes were more common in patients with metastatic disease.Pityriasis Rotunda was associated with the lowest risk of death, (OR: 0.05, 95% CI: 0.003 to 0.89; p = 0.04), while dermatomyositis had a statistically significant higher risk of death (OR: 3.37, 95% CI: 1.01-12.1;p = 0.03).Most patients showed an improvement in their cutaneous abnormalities, following cancer-directed therapy.Conclusion: Paraneoplastic cutaneous manifestations are reported more frequently in patients with a higher burden of disease, especially presence of metastases.Certain cutaneous manifestations have prognostic implication.
Open the resolved locator · 10.7150/jca.88931
Metadata licence: OpenAlex metadata (CC0)